32 results
6-K
LEGN
Legend Biotech Corp
13 May 24
Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
7:01am
to the collaboration from Janssen when placed into service are classified as collaboration prepaid leases on the consolidated financial statements.
(a)Right-of-use … advances within one year, and thus the loan was classified as a long-term liability.
13. SHARE CAPITAL AND SHARE PREMIUM
Shares
March 31,2024
F-3ASR
LEGN
Legend Biotech Corp
19 Mar 24
Automatic shelf registration (foreign)
7:57am
of a corporation with a classified board may be removed only for cause with the approval of a majority of the outstanding shares entitled
to vote
6-K
LEGN
Legend Biotech Corp
20 Nov 23
Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights
6:02am
. Collaboration assets under construction that will be leased to the collaboration from Janssen when placed into service are classified as collaboration … year, nor does the Company expect to repay the funding advances within one year, and thus the loan was classified as a long-term liability.
16
6-K
z6wdnr8bxk9 ql2dx
15 Aug 23
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
6:10am
F-3ASR
qux 8x2ak
26 May 23
Automatic shelf registration (foreign)
9:01am
424B5
kr0is xzv
8 May 23
Prospectus supplement for primary offering
8:45am
CORRESP
gyxfl4iygnc7
30 Sep 22
Correspondence with SEC
12:00am
424B5
2chpa994om
27 Jul 22
Prospectus supplement for primary offering
4:32pm
424B5
ypcjlfe ih38est1v6i
25 Jul 22
Prospectus supplement for primary offering
4:29pm
6-K
EX-99.2
4clf90v68h
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
424B5
r6qjfexmmvh gbqi2xe
17 Dec 21
Prospectus supplement for primary offering
4:16pm
424B5
klyhzqe03o0ymv
14 Dec 21
Prospectus supplement for primary offering
4:40pm
6-K
EX-99.2
2c9lkq8y1
14 Dec 21
Legend Biotech Corporation Announces Proposed Public Offering
4:27pm
6-K
EX-99.1
rkrqp01 o2xpyxwlcbj7
16 Nov 21
Legend Biotech Corp. 6-K
8:30am